ECRM Branded Rx 2009

If current trends in pharmaceutical sales are any indication, retail pharmacy leaders may have to look beyond the prescription department for big gains in store revenues this year. Hammered by a lack of new breakthroughs in research and development, tougher oversight at the Food and Drug Administration, generic competition and a worldwide economy in free fall, the U.S. pharmaceutical market is mired in an era of stagnant sales and declining expectations. And the outlook for an uptick in innovative new therapies from drug makers remains at historically low levels, according to industry experts. Click below to download the PDF of ECRM Branded Rx 2009.